Investors

INMODE IS A LEADING GLOBAL PROVIDER OF INNOVATIVE, ENERGY-BASED,
MINIMALLY AND NON-INVASIVE MEDICAL SOLUTIONS

InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5M Represent 62% YoY Growth. GAAP Earnings per Share of $0.63, 320% YoY Growth

InMode Expects First Quarter 2021 Revenue Between $65.0-$65.4M, Non-GAAP Earnings per Diluted Share Between $0.65-$0.67

InMode to Present at the Needham 20th Annual Virtual Healthcare Conference

Financials & Filings

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us